Cancer detection tests
Dxcover is developing tests for early detection of multiple cancers.
Source: LinkedIn company description · Retrieved October 13, 2026
Dxcover is a clinical-stage liquid biopsy company developing tests for early detection of multiple cancers.
The company employs infrared spectroscopy of circulating pan-omic biomarkers for early cancer detection and identification. Dxcover is based in Scotland, United Kingdom, and is establishing operations in the USA.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Dxcover is developing tests for early detection of multiple cancers.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 26, 2026, September 27, 2026, September 28, 2026, September 30, 2026 and October 8, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.